Economic Evaluation of Cancer Drugs (PDF)

Name: Economic Evaluation of Cancer Drugs
Brand: Taylor & Francis
SKU: 125152959
Price: 61.49 EUR
Availability: OnlineOnly

Using Clinical Trial and Real-World Data (Sprache: Englisch)

Autoren: Iftekhar Khan , Ralph Crott , Zahid Bashir

Schreiben Sie einen Kommentar zu "Economic Evaluation of Cancer Drugs".

Economic Evaluation of Cancer Drugs, Iftekhar Khan, Ralph Crott, Zahid Bashir

Merken

The first book on the design and analysis of not only clinical trials but also how observational non-interventional data using clinical data is applied to economic evaluation and re-imbursement in the context of Cancer. This book is a non technical...

Mehr zum Inhalt Autorenporträt Video

sofort als Download lieferbar

Bestellnummer: 125152959

eBook (pdf) 61.49 €

Download bestellen

Verschenken

30 DeutschlandCard Punkte sammeln

Lastschrift, Kreditkarte, Paypal, Rechnung
Kostenloser tolino webreader

Produktdetails

Produktbeschreibung
Autorenporträt
eBook Hilfe
Biblio. Angaben / Produktdetails

Produktinformationen zu „Economic Evaluation of Cancer Drugs (PDF)“

Autoren-Porträt von Iftekhar Khan, Ralph Crott, Zahid Bashir

Iftekhar Khan is a medical statistician and health economist and a lead statistician at Oxford Unviersity's Center for Statistics in Medicine. Professor Khan is also a Senior Research Fellow in Health Economics at University of Warwick and is a Senior Statistical Assessor within the Licensing Division of the UK Medicine and Health Regulation Agency.

Ralph Crott is a former professor in Pharmacoeconomics at the University of Montreal in Quebec, Canada and former head of the EORTC Health Economics Unit and former senior health economist at the Belgian HTA organization.

Zahid Bashir has over twelve years experience working in the pharmaceutical industry in medical affairs and oncology drug development where he is involved in the design and execution of oncology clinical trials and development of reimbursement dossiers for HTA submission.